Kerstin Hartig-Lavie

Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C

Victor Virlogeux, Pierre Pradat, Kerstin Hartig-Lavie et al. · Liver International · 2017 · 71 citations

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

Pierre Nahon, Marie Najean, Richard Layese et al. · JHEP Reports · 2021 · 46 citations · Full text

Hepatology, Medical Imaging, Cancer Detection +13

Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy

Yasmina Chouik, Domitille Erard, H. Demian et al. · Frontiers in Immunology · 2023 · 29 citations · Full text

Boceprevir and telaprevir‐based triple therapy for chronic hepatitis <scp>C</scp>: virological efficacy and impact on kidney function and model for end‐stage liver disease score

Victor Virlogeux, Pierre Pradat, François Bailly et al. · Journal of Viral Hepatitis · 2014 · 25 citations

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia

Patrick Miailhes, Kerstin Hartig-Lavie, Victor Virlogeux et al. · Clinical Microbiology and Infection · 2018 · 12 citations

Hepatology, Hepatitis C, Direct-acting Antiviral Therapy +11